Erythropoietin (EPO) was named for its long-appreciated hormonal effect of maintaining the circulating erythrocyte mass. In recent years, however, it has been recognized that EPO is a member of the ...
Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health issue, affecting approximately 30% of the population, with no effective pharmacological treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback